
Morningside is a private investment group founded in 1986 by the Chan family of Hong Kong. The firm makes venture capital and private equity investments in companies with novel science and technology, characterized by a long-term outlook in company-building.
Average disclosed round size is $61.2M (across 82 rounds with reported amounts).
Portfolio
78
Fund Size
—
Top Stage
Series B
Last 12 Mo
4
Team
DW
Dan White
Investor
JH
Jawanza Hughes
Chief Investment Officer
SM
Stephanie Monaghan O'Brien
Investment Professional
WN
Wes Nolin
Biotech & Healthcare Venture Capital
EC
Elijah Chang
Digital Health VC
PH
Peter Hu
Digital Health VC
R(
Ruoxi (Rosy) Hu
Biotech VC
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
93 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Series A | $5M | Jul 2026 | |
| Series A | $10.8M | Apr 2026 | |
| Seed | $8.5M | Oct 2025 | |
| Series B | $28M | Oct 2025 | |
| CCyted Health | Series B | $44M | Sep 2025 |
| AAccropeutics Inc. | Series B | $12M | Mar 2025 |
| Seed | $4M | Feb 2025 | |
| Series C | $105M | Jan 2025 | |
| AAlentis | Series D | $181.4M | Nov 2024 |
| Series A | $24M | Jan 2024 | |
| JJitjatjo | Series B | $30M | Dec 2023 |
| Series A | $32M | Aug 2023 | |
| Series A | $10M | Jan 2023 | |
| VValitor, Inc. | Series B | $28M | Oct 2022 |
| EEpigenic Therapeutics Co., Ltd. | Series A | $20M | Aug 2022 |
| Seed | $6M | May 2022 | |
| AAdiso Therapeutics | Seed | — | Mar 2022 |
| Series A | $12M | Feb 2022 | |
| Series B | $30M | Jan 2022 | |
| Series B | $105M | Nov 2021 | |
| Series C | $50M | Nov 2021 | |
| Series A | $12.5M | Nov 2021 | |
| Unknown | $17M | Sep 2021 | |
| Series D | $100M | Sep 2021 | |
| Series B | $54.5M | Sep 2021 |
Page 1 of 4
Top Co-Investors
Shunwei Capital5 shared
Lightspeed Venture Partners4 shared
IDG Capital4 shared
General Catalyst4 shared
Frazier Healthcare Partners4 shared
OrbiMed4 shared
Fidelity Investments3 shared
Foresite Capital3 shared
Matrix Partners3 shared
Polaris Partners3 shared
Legend Capital3 shared
DCM Ventures3 shared
Pivotal Life Sciences3 shared
Indicator Ventures3 shared
Ally Bridge Group3 shared
Bain Capital Life Sciences3 shared
Novo Capital3 shared
Sofinnova Partners3 shared
Last updated: 7 September 2026